Trial reportPediatric radiology2026
Feasibility of reducing the contrast dose in infants and children with complex congenital heart disease using virtual monoenergetic images on dual-layer spectral detector computed tomography.
Trial report in Pediatric radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundVirtual monoenergetic imaging (VMI) with dual-layer spectral detector computed tomography (CT) enables keV optimization, offering the potential for contrast dose reduction, particularly beneficial in pediatric imaging. However, its clinical utility in infants and children with complex congenital heart disease (CHD) remains underexplored.
objectiveTo investigate the feasibility of reducing the contrast dose and the optimal keV of virtual monoenergetic images (VMIs) on dual-layer spectral detector CT in infants and children with complex CHD. MATERIALS AND
methodsProspectively enrolled 80 infants and children with complex CHD and underwent preoperative dual-layer spectral detector CT. Patients were randomly divided into two groups: group A (n=36, standard dose, 1.5-2 ml/kg) and group B (n=44, low dose, 1 ml/kg). Conventional image and VMIs in range of 40-85 keV were reconstructed in group B while only conventional image was reconstructed in group A. Image quality was evaluated using qualitative scores and objective metrics including CT-value, standard deviation (SD), signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR) for the pulmonary artery and ascending aorta.
resultsGroup B received 24% less contrast than group A [8.0 (5.0; 11.0) ml vs. 10.5 (8.0; 21.0) ml, P<0.05]. VMI 40 keV in group B yielded the highest CT-value, SNR, CNR of pulmonary artery, and ascending aorta among different VMIs, and significantly outperformed conventional image in group A (P<0.05). Subjective evaluation score on VMI 40-50 keV of group B was significantly higher than conventional image of group A (P<0.05). Diagnostic accuracy for CHD at 40-50 keV in group B was 97.7%, significantly higher than group A (93.4%, P<0.05), while no significant difference in sensitivity and specificity.
conclusionVMI 40 keV in dual-layer spectral detector CT can significantly improve image quality, allowing contrast dose reduction in infants and children with complex CHD without compromising diagnostic performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.